News
- Author:
- Jessica Craig
Publish date: July 20, 2016
Key clinical point: Cabozantinib significantly improved overall survival, compared with everolimus in patients with renal cell carcinoma. Major fin...
News
- Author:
- Jessica Craig
Publish date: July 18, 2016
Key clinical point: Delaying surgery for 11 weeks after the end of radiochemotherapy does not improve pathologic complete response rates in patien...
News
- Author:
- Jessica Craig
Publish date: July 13, 2016
Key clinical point: Olanzapine significantly reduced episodes of nausea, compared with placebo.
Major finding: The proportion of patients who exp...
News
- Author:
- Jessica Craig
Publish date: July 12, 2016
Key clinical point: Irinotecan plus cisplatin is no better than paclitaxel plus carboplatin for women with ovarian clear cell carcinoma
Major find...
News
- Author:
- Jessica Craig
Publish date: July 11, 2016
Key clinical point: Standard measures are acceptable indicators of good quality end of life care for patients with hematologic malignancies.
Major...
News
- Author:
- Jessica Craig
Publish date: July 8, 2016
News
- Author:
- Jessica Craig
Publish date: July 5, 2016
Key clinical point: Survivors of pediatric-onset cancer are at increased risk for developing endocrine abnormalities.
Major finding: Overall, 44%...
News
- Author:
- Jessica Craig
Publish date: July 5, 2016
Key clinical point: Survivors of pediatric-onset cancer are at increased risk for developing endocrine abnormalities. Major finding: Overall, 44% o...
News
- Author:
- Jessica Craig
Publish date: July 1, 2016
Key clinical point: In male patients with adult-onset germ cell tumors, cisplatin-based chemotherapy may be associated with hearing loss.
Major fi...
Article
- Author:
- Jessica Craig
Publish date: June 30, 2016
News
- Author:
- Jessica Craig
Publish date: June 29, 2016
News
- Author:
- Jessica Craig
Publish date: June 29, 2016
News
- Author:
- Jessica Craig
Publish date: June 29, 2016
Key clinical point: A phase I trial indicates that nivolumab is safe and shows durable activity as a first-line therapy in treating patients with ...
News
- Author:
- Jessica Craig
Publish date: June 29, 2016
Key clinical point: Nivolumab administered in combination with platinum-based doublet chemotherapy may improve response rates. However, the combin...
News
- Author:
- Jessica Craig
Publish date: June 27, 2016
Key clinical point: Higher implicit racial bias among oncologists was linked with less-supportive care for black patients.
Major finding: Higher ...
